IBOV 205,835.29 ▼ 0.52% IPSA 11,164.13 ▲ 0.36% IPC MEX 65,312.46 ▲ 0.52% MERVAL 2,896,853 ▲ 0.95% COLCAP 2,589.04 ▲ 0.25% BVL PERÚ 60,220.93 ▲ 0.91% USD/BRL4.98▼ 0.12% USD/MXN18.03▲ 0.27% USD/CLP971.50▼ 0.11% USD/COP3,232▲ 0.75% USD/PEN3.44▼ 0.19% USD/ARS1,520— 0.00% USD/UYU40.09▲ 2.87% USD/PYG5,835▲ 3.25% USD/BOB11.90▲ 2.31% USD/DOP60.10▲ 4.07% USD/CRC454.50▲ 2.57% USD/GTQ7.64▲ 3.36% USD/HNL26.86▲ 3.49% USD/NIO36.62▲ 0.26% USD/VES871.68▲ 0.04% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.68▲ 1.99% EUR/BRL5.60▼ 4.67% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 205,835.29 ▼ 0.52% IPSA 11,164.13 ▲ 0.36% IPC MEX 65,312.46 ▲ 0.52% MERVAL 2,896,853 ▲ 0.95% COLCAP 2,589.04 ▲ 0.25% BVL PERÚ 60,220.93 ▲ 0.91% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Wednesday, October 7, 2026

Trump Taps RFK Jr. as Health Chief: Medical Freedom Champion

By · November 15, 2024 · 2 min read

Donald Trump has nominated Robert F. Kennedy Jr. as Secretary of Health and Human Services. Kennedy, an environmental advocate, has gained prominence for his views on health policy.

His nomination suggests a potential shift in U.S. health policy. Kennedy is a vocal advocate for health freedom and informed consent. His book, “The Real Anthony Fauci,” became a bestseller during the COVID-19 pandemic.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Kennedy raises questions about the pharmaceutical industry’s influence and government health policies. Kennedy has been a prominent figure advocating for medical freedom.

He emphasizes the importance of individual choice in healthcare decisions. During the pandemic, Kennedy became a vocal critic of vaccine mandates.

He expressed concerns about the rapid development and deployment of COVID-19 vaccines, advocating for more transparency and rigorous testing.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil stocks jump 7.7%, real up 4%, after the vote”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Kennedy argues that mandating vaccines infringes on personal liberties and the right to informed consent. If confirmed, Kennedy may introduce new perspectives to health policy.

Debate Over Kennedy’s Nomination

He has suggested reallocating some research funding from infectious diseases to chronic illnesses. Kennedy also advocates for increased transparency in health regulation and pharmaceutical research.

His nomination has sparked debate about balancing personal freedom with public health considerations. Kennedy’s nomination will undergo Senate scrutiny. Some senators have expressed interest in hearing his views directly.

The confirmation hearings will likely explore Kennedy’s ideas on public health and medical freedom. Kennedy’s stance resonates with those who prioritize personal freedom over governmental intervention in healthcare.

Kennedy’s nomination has elicited varied responses from health professionals. Some view him as a proponent of medical choice and government accountability. Others express concerns about potential changes to established health policies

Kennedy’s potential leadership could bring a fresh perspective to health policy discussions. His approach emphasizes individual health choices and transparency in medical research.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.